OFIX
Orthofix Medical Inc. Healthcare - Medical Devices Investor Relations →
Orthofix Medical Inc. (OFIX) closed at $9.45 as of 2026-06-19, trading 38.9% below its 200-week moving average of $15.45. This places OFIX in the extreme value zone. The stock moved further from the line this week, up from -40.0% last week. The 14-week RSI sits at 35, indicating neutral momentum.
Trading volume is running at 1.0x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.81 ratio) is neutral — neither side is clearly dominating.
Over the past 1734 weeks of data, OFIX has crossed below its 200-week moving average 22 times. On average, these episodes lasted 34 weeks. Historically, investors who bought OFIX at the start of these episodes saw an average one-year return of +11.7%.
With a market cap of $382 million, OFIX is a small-cap stock. The company generates a free cash flow yield of 5.8%, which is healthy. Return on equity stands at -13.4%. The stock trades at 0.9x book value.
Share count has increased 97.6% over three years, indicating dilution. This stock also meets the Yartseva multibagger criteria as a small-cap with strong free cash flow yield and reasonable book value.
Over the past 33.3 years, a hypothetical investment of $100 in OFIX would have grown to $97, compared to $3011 for the S&P 500. OFIX has returned -0.1% annualized vs 10.8% for the index, underperforming the broader market over this period.
In the past 12 months, corporate insiders have made 5 open-market purchases totaling $4,105,383. Notably, these purchases occurred while OFIX is trading below its 200-week moving average — insiders are buying when the market is most pessimistic.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: OFIX vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After OFIX Crosses Below the Line?
Across 22 historical episodes, buying OFIX when it crossed below its 200-week moving average produced an average return of +8.3% after 12 months (median +12.0%), compared to +13.2% for the S&P 500 over the same periods. 68% of those episodes were profitable after one year. After 24 months, the average return was +30.4% vs +30.8% for the index.
Each line shows $100 invested at the moment OFIX crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Bean Score Experimental
The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. OFIX currently has negative free cash flow, so price-based dislocation levels are not available. The score still tracks yield deviation from baseline.
Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end
Signal Accuracy Collecting Data
The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"
Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.
Dislocation Scores Experimental
Each score measures deviation from OFIX's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.
Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.
Historical Touches
OFIX has crossed below its 200-week MA 22 times with an average 1-year return of +11.7% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Mar 1993 | Jun 1993 | 10 | 8.4% | +7.7% | -3.1% |
| Jun 1993 | Feb 1994 | 34 | 23.3% | +12.8% | -3.1% |
| Jul 1994 | Aug 1994 | 5 | 5.4% | +72.2% | -4.3% |
| Oct 1995 | May 1996 | 31 | 42.8% | -1.3% | -3.1% |
| Jun 1996 | Jun 1997 | 50 | 41.7% | -10.0% | -16.0% |
| Jun 1997 | Sep 1997 | 13 | 20.3% | +23.5% | -6.7% |
| Dec 1997 | Dec 1997 | 1 | 6.1% | +22.4% | -11.1% |
| Feb 1998 | Mar 1998 | 1 | 1.3% | +24.4% | -16.0% |
| Aug 1998 | Sep 1998 | 1 | 0.1% | +18.3% | -18.7% |
| Sep 1998 | Oct 1998 | 5 | 9.8% | +16.0% | -16.5% |
| Jul 2004 | Aug 2004 | 4 | 6.2% | +48.9% | -68.9% |
| Nov 2005 | Dec 2005 | 3 | 1.9% | +18.9% | -74.1% |
| Jun 2006 | Jul 2006 | 3 | 2.6% | +23.7% | -74.5% |
| Jul 2007 | Aug 2007 | 1 | 0.7% | -44.6% | -77.8% |
| Feb 2008 | Mar 2010 | 109 | 77.6% | -48.7% | -75.1% |
| Apr 2010 | Feb 2011 | 45 | 20.6% | -5.7% | -73.2% |
| Mar 2011 | Mar 2011 | 2 | 0.2% | +25.6% | -70.3% |
| Apr 2013 | Jun 2014 | 60 | 41.5% | -8.5% | -72.6% |
| Jul 2014 | Aug 2014 | 2 | 2.2% | +0.9% | -71.4% |
| Sep 2014 | Mar 2015 | 30 | 16.1% | +14.6% | -70.7% |
| May 2015 | May 2015 | 2 | 3.2% | +35.0% | -70.3% |
| Oct 2019 | Ongoing | 347+ | 66.3% | Ongoing | -77.2% |
| Average | 34 | — | +11.7% | — |
Frequently Asked Questions
Is OFIX below its 200-week moving average?
Yes. As of 2026-06-19, Orthofix Medical Inc. (OFIX) is trading 38.9% below its 200-week moving average of $15.45. The current price is $9.45.
What is OFIX's 200-week moving average price?
Orthofix Medical Inc.'s 200-week moving average is $15.45 as of 2026-06-19. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when OFIX drops below its 200-week moving average?
OFIX has crossed below its 200-week moving average 22 times in our data. On average, buying at that moment produced a one-year return of +11.7%. These dips have historically been decent entry points. These episodes lasted 34 weeks on average.
Is OFIX a good value right now?
Here's what our data says about OFIX as of 2026-06-19: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 35. Free cash flow yield is 5.8%. Return on equity is -13.4%. Price-to-book is 0.9x. This is not a buy or sell recommendation — always do your own research.
How does OFIX compare to the S&P 500?
Over the past 33.3 years, $100 invested in OFIX would have grown to $97, compared to $3011 for the S&P 500. That's -0.1% annualized vs 10.8% for the index. OFIX has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-06-19